Annual Drug Patent Expirations for BESIVANCE
Besivance is a drug marketed by Bausch And Lomb and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
This drug has fifty-three patent family members in nineteen countries.
The generic ingredient in BESIVANCE is besifloxacin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the besifloxacin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
